Antimicrobial peptide PET/CT imaging with gallium-68 appears to break through previous roadblocks in differentiating infections and sterile inflammatory processes, according to a study published Jan. 16 in the Journal of Nuclear Medicine.

A tiny molecular imaging system could be used on the field to measure brain injury or in the lab to capture individual molecules that betray the biology of cancer, neurodegenerative diseases such as Alzheimer's and viruses like human immunodeficiency virus (HIV). 

Never-before-seen preclinical fluorescence imaging has broken new ground in the understanding of how memories are formed by nerve cells in the brain.

A partnership between the United Kingdom-based Alzheimer’s Society and the Alzheimer’s Drug Discovery Foundation is engaged to fund up to $1.5 million for Alzheimer’s drug development programs.

Electron microscopy researchers have been given the Banco Bilbao Vizcaya Argentaria (BBVA) Foundation Frontiers of Knowledge Award for pushing the technology into the picometer range—or one-hundredth the diameter of a hydrogen atom.

Combining CT angiography (CTA) and SPECT MPI is useful for the evaluation of coronary artery disease (CAD) and shows more diagnostic benefit than just one of the modalities or consecutive use of the two technologies, according to a study published Jan. 1 in the Journal of Nuclear Medicine.

Breast-specific imaging systems are by far the most sensitive and specific molecular modalities for the visualization of breast tumors, according to a review published Jan. 16 in the Journal of Nuclear Medicine.

New copper-64 and gallium-68 chelating platforms are being developed by Macrocyclics, a subsidiary of AREVA Med, the company announced Jan. 10. Four new formulas would expand the company’s PET imaging portfolio.